Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

In a press release, the Dutch soccer club stated that a hacker unlawfully gained access to parts of its IT systems. With the help of external cybersecurity experts, an internal investigation was ...

Our Ajax TV schedule provides the information you need to follow the Netherlands’ most successful club. AFC Ajax was founded in 1900 and has played continuously in the top division Eredivisie since ...

The government has halted all testing of the UK Army's new armoured vehicle - known as the Ajax - after a soldier was injured in a recent trial. The soldier reported vibration symptoms after riding ...

Ajax's Eredivisie match against Groningen at the Johan Cruyff Arena was called off after supporters ignited fireworks and flares behind one of the goals. Referee Bas Nijhuis led the players off the ...

Sunday’s Eredivisie match between Ajax and Groningen was abandoned in the sixth minute after supporters set off fireworks. The Dutch top-flight match at the Johan Cruyff Arena in Amsterdam kicked off ...

After years of delays, injuries, and spiralling costs, the British Army’s AJAX armoured vehicle has finally been declared ready for limited service. Once hailed as a cutting-edge reconnaissance ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Note, this article deals with client-side JavaScript. For a client and server-side JavaScript ...

Francesco Farioli has resigned from his post as Ajax manager, citing a difference in "vision" and "timeframes" for club's goals. Sources have told ESPN there was a difference in opinion behind the ...

Though safety concerns have led some drugmakers to shy away from so-called JAK inhibitors, the startup says it’s found a way to address their weaknesses. “Nobody's taking the same approach that we're ...